Package 1 - four-valent influenza vaccine for the 2021/2022 season (split virion), inactivated, indicated for active immunization of adults and children from the age of 6 months in the prevention of influenza caused by two subtypes of A virus and two types of Group B virus, Package: 10 pre-filled syringes with a capacity of 0.5 ml - 210 op. ;

Package 2 - meningococcal vaccine containing purified polysaccharide antigen conjugated with tetanus toxoiden, adsorbed on hydrated aluminium hydroxide, intended for active evaporation of children from 2 months of age, adolescents and adults for the prevention of infections caused by Neisseria meningitidis group C (strain C11); used according to official recommendations; package: 0.5 ml pre-filled syringe - 516 pcs.

Quadvalent influenza vaccine for 2021/2022 season (split virion); inactivated, indicated for active immunization of adults and children from the age of 6 months of age for the prevention of influenza caused by two subtypes of A virus and two types of group B virus; packaging: 10 pre-filled syringes with a capacity of 0.5 ml. 210 op.

Meningococcal vaccine, containing purified polysaccharide antigen conjugated with tetanus toxoiden, adsorbed on hydrated aluminium hydroxide, intended to actively evaporate children from 2 months of age, adolescents and adults for the prevention of infections caused by Neisseria meningitidis group C (strain c11); used according to official recommendations; packaging: amule-syringe with a capacity of 0.5 ml. - 516 pcs.